Presentation Information
[28P-am442]A research study on adherence, efficacy and safety of oral GLP-1 receptor agonist Rybelsus® (Semaglutide) tablets.
○Fumie Kato1, Chihiro Ito1, Takuto Inoue1, Tatsuro Satomi2, Shinji Kasai2, Ken-yuh Hasumoto1, Keiko Hosohata1 (1. Himeji Dokkyo University, 2. Ebira Pharmacy)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.